Meridian Bioscience Inc (VIVO) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Meridian Bioscience Inc   (NASDAQ: VIVO)


Meridian Bioscience Inc 's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Meridian Bioscience Inc 's ROA in the first quarter of 2023?
Meridian Bioscience Inc recorded a cumulative net loss of $-3 million during 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -0.58%.

However, within the Healthcare sector 261 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Dec 31 2022 quarter, so far to 561, from total ROA ranking in the fourth quarter of 2022 at 670.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2022)
I. Quarter		 (Sep 30 2022)
IV. Quarter		 (Jun 30 2022)
III. Quarter		 (Mar 31 2022)
II. Quarter		 (Dec 31 2021)
I. Quarter
Y / Y Total Assets Change -0.41 % -1.48 % 4.33 % 7.43 % 8.19 %
Y / Y Net Income Change - -14.3 % - 9.31 % -42.72 %
Net Income (TTM) in million -3 42 43 62 60
Return On Assets (TTM) -0.58 % 9.13 % 9.3 % 13.52 % 13.22 %
VIVO's Total Ranking # 561 # 670 # 414 # 388 # 273
Total Assets (TTM) in million 457 463 466 472 459
Seq. Total Assets Change -1.37 % -0.61 % -1.25 % 2.87 % -2.43 %
Seq. Net Income Change - - - 87.43 % 130.43 %

VIVO's 5 Years Annual ROA >> Back to VIVO Management Effectiveness >> Compare VIVO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 6
Sector # 262
Overall # 3230

Return On Assets Statistics
High Average Low
22.85 %
14.85 %
-0.58 %
(Jun 30 2013)  





Financial Statements
Meridian Bioscience Inc 's Assets $ 457 million VIVO's Balance sheet
Meridian Bioscience Inc 's Income $ -30 million Quarterly VIVO's Income Statement
VIVO's Income by Division See VIVO's Income by Division



Annual Return On Assets (Sep 30 2022)
FY 2022		 (Sep 30 2021)
FY 2021		 (Sep 30 2020)
FY 2020		 (Sep 30 2019)
FY 2019		 (Sep 30 2018)
FY 2018
Y / Y Total Assets Change 2.97 % 10.97 % 24.51 % 29.48 % 0.64 %
Total Assets in million 463 450 405 325 251
Y / Y Net Income Change -40.54 % 54.61 % 89.43 % 2.23 % 10.63 %
Net Income in million 42 71 46 24 24
Annual Return On Assets 9.17 % 15.88 % 11.4 % 7.49 % 9.49 %

VIVO's 5 Years Annual ROA >> Back to VIVO Management Effectiveness >> Compare VIVO ROA to its Competitors



Comment on VIVO's ROA in the fiscal year ending 2022
In the fiscal year 2022 Meridian Bioscience Inc 's ROA decreased compared to previous year to 9.17 %, due to deterioration of net income -40.54 % to $42.46 million, from $71.41 million a year ago, as VIVO's assets were $463.10 million.


More Return On Assets Ratios
VIVO's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VIVO's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VIVO's Competitors
Subscribers only: Roa for Meridian Bioscience Inc 's Suppliers
Subscribers only: Return On Assets for VIVO's Customers

You may also want to know
VIVO's Roi VIVO's Inventory Turnover Ratio VIVO's Growth Rates VIVO's Dividend Comparisons
VIVO's Profitability Ratios VIVO's Asset Turnover Ratio VIVO's Dividend Growth
VIVO's Roe VIVO's Valuation Ratios VIVO's Financial Strength Ratios VIVO's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector ROA

Date modified: 2026-09-26T06:55:37+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.